MeSH term
Frequency | Condition_Probility | Acute Disease | 8 | 0.0 |
Adult | 42 | 0.0 |
Bone Marrow Transplantation/*statistics & numerical data | 2 | 2.0 |
Comparative Study | 55 | 0.0 |
Cord Blood Stem Cell Transplantation/*statistics & numerical data | 2 | 2.0 |
Fetal Blood/transplantation | 2 | 2.0 |
Humans | 839 | 0.0 |
Leukemia/*therapy | 2 | 1.0 |
Patient Selection | 2 | 1.0 |
Aged | 20 | 0.0 |
Time Factors | 57 | 0.0 |
Aged, 80 and over | 10 | 0.0 |
Balloon Dilatation/adverse effects/*instrumentation | 2 | 4.0 |
Esophageal and Gastric Varices/therapy | 2 | 4.0 |
Esophagus/*injuries/radiography | 2 | 4.0 |
Fatal Outcome | 3 | 0.0 |
Female | 78 | 0.0 |
Foreign Bodies/*radiography | 2 | 4.0 |
Gastrointestinal Hemorrhage/therapy | 2 | 4.0 |
*Medical Errors | 2 | 4.0 |
Pleural Cavity/*radiography | 2 | 4.0 |
Tomography, X-Ray Computed | 3 | 0.0 |
Animals | 370 | 0.0 |
Antineoplastic Agents/*pharmacology/therapeutic use | 3 | 3.0 |
DNA Repair | 2 | 0.0 |
Drug Resistance, Neoplasm | 11 | 2.0 |
Gene Expression | 34 | 0.0 |
Biological Markers | 2 | 0.0 |
Genes, Tumor Suppressor | 2 | 0.0 |
Oncogenes | 2 | 0.0 |
*Apoptosis | 14 | 0.0 |
Cell Division | 29 | 0.0 |
Cell Survival | 4 | 0.0 |
Cyclins/metabolism | 5 | 1.0 |
DNA-Binding Proteins/*physiology | 36 | 7.0 |
*Milk Proteins | 101 | 21.0 |
Models, Biological | 27 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 382 | 0.0 |
Trans-Activators/*physiology | 43 | 16.0 |
Base Sequence | 117 | 0.0 |
DNA Primers | 24 | 0.0 |
DNA-Binding Proteins/*metabolism | 211 | 10.0 |
Electrophoretic Mobility Shift Assay | 10 | 2.0 |
Interferon Type I/*metabolism | 5 | 31.0 |
Receptors, Interferon/chemistry/*metabolism | 4 | 66.0 |
Trans-Activators/*metabolism | 223 | 23.0 |
Tumor Cells, Cultured | 214 | 1.0 |
Tyrosine/*metabolism | 10 | 3.0 |
Binding, Competitive | 3 | 0.0 |
Enzyme Activation | 60 | 1.0 |
Gene Expression Regulation, Enzymologic/physiology | 2 | 2.0 |
Interferons/*physiology | 5 | 29.0 |
NF-kappa B/*metabolism | 11 | 1.0 |
Phosphoproteins/*metabolism | 12 | 2.0 |
Promoter Regions (Genetics) | 55 | 1.0 |
Research Support, Non-U.S. Gov't | 607 | 0.0 |
Trans-Activators/metabolism | 136 | 14.0 |
Transcription, Genetic/physiology | 3 | 1.0 |
Blotting, Western | 70 | 1.0 |
Cell Movement | 5 | 0.0 |
Cells, Cultured | 140 | 0.0 |
DNA/metabolism | 67 | 4.0 |
DNA-Binding Proteins/metabolism | 134 | 7.0 |
Dose-Response Relationship, Drug | 48 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 23 | 2.0 |
NF-kappa B/metabolism | 25 | 3.0 |
Phosphorylation | 273 | 3.0 |
Precipitin Tests | 40 | 1.0 |
Protein Binding | 81 | 0.0 |
Protein Kinases/*metabolism | 2 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 67 | 7.0 |
Serine/metabolism | 15 | 4.0 |
Signal Transduction | 176 | 3.0 |
Trans-Activation (Genetics) | 35 | 2.0 |
Tyrosine/metabolism | 87 | 7.0 |
p38 Mitogen-Activated Protein Kinases | 26 | 4.0 |
Enzyme Activation/drug effects | 25 | 2.0 |
Interleukin-10/*pharmacology | 6 | 6.0 |
JNK Mitogen-Activated Protein Kinases | 9 | 1.0 |
Mitogen-Activated Protein Kinases/*metabolism | 11 | 2.0 |
Protein-Tyrosine Kinase/*metabolism | 56 | 6.0 |
Proteins/metabolism | 31 | 3.0 |
*Proto-Oncogene Proteins | 77 | 4.0 |
Rats | 46 | 0.0 |
Signal Transduction/drug effects | 25 | 3.0 |
Antineoplastic Agents/*pharmacology | 18 | 1.0 |
Apoptosis/*drug effects | 14 | 1.0 |
Cell Line | 244 | 1.0 |
*Drug Resistance, Neoplasm | 2 | 1.0 |
Flow Cytometry | 20 | 0.0 |
Gene Expression Regulation, Neoplastic/drug effects | 7 | 1.0 |
Herpesvirus 4, Human/*physiology | 3 | 5.0 |
Polymerase Chain Reaction | 17 | 0.0 |
Protein p53/metabolism | 4 | 0.0 |
RNA, Messenger/genetics/metabolism | 13 | 0.0 |
*Transcription Factors | 31 | 1.0 |
Binding Sites | 66 | 0.0 |
Carrier Proteins/physiology | 2 | 1.0 |
*Intracellular Signaling Peptides and Proteins | 21 | 2.0 |
Proteins/physiology | 6 | 4.0 |
*Repressor Proteins | 39 | 3.0 |
*Signal Transduction | 104 | 5.0 |
Chemokines/biosynthesis | 2 | 5.0 |
Enzyme Inhibitors/pharmacology | 44 | 1.0 |
Fetus | 3 | 0.0 |
Flavonoids/pharmacology | 6 | 1.0 |
Gene Expression/drug effects | 19 | 2.0 |
Gene Expression Regulation | 52 | 1.0 |
Imidazoles/pharmacology | 6 | 2.0 |
Interferon-beta/*pharmacology | 15 | 25.0 |
Mitogen-Activated Protein Kinases/antagonists & inhibitors/metabolism | 2 | 2.0 |
NF-kappa B/physiology | 2 | 2.0 |
Pyridines/pharmacology | 6 | 2.0 |
Signal Transduction/*drug effects | 26 | 7.0 |
Transcription Factors/metabolism | 35 | 2.0 |
Alleles | 3 | 0.0 |
Case-Control Studies | 4 | 0.0 |
Cohort Studies | 3 | 0.0 |
Male | 49 | 0.0 |
Molecular Sequence Data | 126 | 0.0 |
Reference Values | 5 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Cell Division/drug effects | 37 | 1.0 |
DNA-Binding Proteins/chemistry/*genetics/*metabolism | 4 | 11.0 |
Dimerization | 38 | 2.0 |
Interferon Type I, Recombinant/*pharmacology | 11 | 22.0 |
Trans-Activators/chemistry/*genetics/*metabolism | 4 | 22.0 |
Transcription Factors/genetics/metabolism | 6 | 1.0 |
Antigens, CD/metabolism | 14 | 1.0 |
Carcinoma, Hepatocellular/metabolism | 3 | 3.0 |
Cell Compartmentation | 3 | 0.0 |
Cell Membrane/metabolism | 9 | 0.0 |
Cytosol/metabolism | 5 | 0.0 |
Liver Neoplasms/metabolism | 2 | 2.0 |
Membrane Glycoproteins/metabolism | 9 | 1.0 |
Recombinant Proteins/metabolism/pharmacology | 5 | 4.0 |
Acetylation | 2 | 0.0 |
Genes, MHC Class II | 4 | 1.0 |
Histones/metabolism | 2 | 0.0 |
Interferon Type II/*metabolism/pharmacology | 3 | 25.0 |
Kinetics | 49 | 0.0 |
*Nuclear Proteins | 18 | 0.0 |
Phosphoproteins/metabolism | 16 | 2.0 |
2',5'-Oligoadenylate Synthetase/biosynthesis | 2 | 100.0 |
Blotting, Northern | 18 | 0.0 |
Genes, Reporter | 29 | 1.0 |
Interleukin-1/*metabolism/pharmacology | 2 | 11.0 |
Protein Biosynthesis | 11 | 0.0 |
Signal Transduction/drug effects/physiology | 13 | 5.0 |
Transfection | 150 | 1.0 |
3T3 Cells | 35 | 1.0 |
DNA-Binding Proteins/genetics/*metabolism | 57 | 5.0 |
Interferon-alpha/metabolism/*pharmacology | 4 | 50.0 |
Mice | 236 | 0.0 |
Parainfluenza Virus 2, Human/physiology | 2 | 100.0 |
Rubulavirus/*physiology | 2 | 100.0 |
Species Specificity | 6 | 0.0 |
Trans-Activators/genetics/*metabolism | 54 | 14.0 |
Arginine/*metabolism | 3 | 6.0 |
Baculoviridae/genetics | 3 | 1.0 |
*Nuclear Localization Signal | 3 | 10.0 |
Spodoptera | 6 | 2.0 |
alpha Karyopherins/*metabolism | 2 | 66.0 |
Active Transport, Cell Nucleus | 18 | 7.0 |
Antibodies, Monoclonal/pharmacology | 6 | 0.0 |
Cell Nucleus/metabolism | 70 | 3.0 |
Phosphorylation/drug effects | 38 | 4.0 |
DNA-Binding Proteins/genetics/metabolism | 9 | 1.0 |
Genes, Dominant | 12 | 1.0 |
Interferon Type II/antagonists & inhibitors/*pharmacology | 2 | 50.0 |
Interferon-beta/pharmacology | 9 | 20.0 |
Interleukin-1/pharmacology | 4 | 0.0 |
Rats, Sprague-Dawley | 7 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 47 | 0.0 |
Trans-Activators/genetics/metabolism | 8 | 4.0 |
*Transforming Growth Factor beta | 2 | 1.0 |
Tumor Necrosis Factor-alpha/pharmacology | 8 | 0.0 |
*Gene Expression Regulation | 27 | 1.0 |
Interferon Type I/metabolism | 3 | 60.0 |
Oligonucleotide Array Sequence Analysis | 17 | 1.0 |
Proteins/genetics/metabolism | 4 | 2.0 |
Transcription Factors/*metabolism | 21 | 1.0 |
Variation (Genetics) | 3 | 0.0 |
Zinc Fingers | 3 | 0.0 |
Jurkat Cells | 16 | 1.0 |
RNA, Messenger/biosynthesis | 23 | 1.0 |
Receptors, Interferon/metabolism | 17 | 43.0 |
Transcription, Genetic/drug effects | 12 | 1.0 |
Cell Division/genetics | 3 | 0.0 |
Cell Transformation, Neoplastic/*genetics | 4 | 2.0 |
Cloning, Molecular | 15 | 0.0 |
Gene Expression Regulation/drug effects | 19 | 2.0 |
*Gene Expression Regulation, Neoplastic | 8 | 0.0 |
*Genes, BRCA1 | 2 | 0.0 |
Kidney | 4 | 1.0 |
Mutation | 44 | 0.0 |
Amino Acid Sequence | 71 | 0.0 |
Interleukin-12/pharmacology | 5 | 10.0 |
Mice, Inbred BALB C | 18 | 0.0 |
Apoptosis/genetics | 4 | 1.0 |
DNA-Binding Proteins/genetics | 6 | 0.0 |
Exons/genetics | 2 | 0.0 |
Fibroblast Growth Factor 2/genetics | 2 | 6.0 |
Image Processing, Computer-Assisted | 2 | 0.0 |
Immunohistochemistry | 24 | 0.0 |
In Situ Hybridization | 6 | 0.0 |
Mutation/genetics | 6 | 0.0 |
Receptors, Fibroblast Growth Factor/*genetics | 2 | 0.0 |
Signal Transduction/genetics | 9 | 3.0 |
Trans-Activators/genetics | 6 | 2.0 |
Transcription, Genetic/genetics | 3 | 0.0 |
Active Transport, Cell Nucleus/physiology | 4 | 6.0 |
Interferon Type II/metabolism | 23 | 10.0 |
Phosphoserine/*metabolism | 2 | 7.0 |
*Protein-Serine-Threonine Kinases | 7 | 0.0 |
Proto-Oncogene Proteins/metabolism | 13 | 1.0 |
Signal Transduction/physiology | 20 | 2.0 |
Child | 4 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Interferon Type II/*physiology | 13 | 20.0 |
Interleukin-12/*physiology | 4 | 21.0 |
Mycobacterium Infections/*genetics/immunology | 2 | 100.0 |
Receptors, Interferon/genetics | 4 | 25.0 |
Receptors, Interleukin/genetics | 2 | 6.0 |
Syndrome | 2 | 0.0 |
Carrier Proteins/metabolism | 6 | 0.0 |
Platelet-Derived Growth Factor/*pharmacology | 2 | 2.0 |
RNA, Messenger/metabolism | 37 | 0.0 |
Reactive Oxygen Species/metabolism | 3 | 0.0 |
Signal Transduction/drug effects/*physiology | 12 | 5.0 |
src-Family Kinases/antagonists & inhibitors/metabolism | 2 | 15.0 |
Glutathione Transferase/metabolism | 6 | 0.0 |
Interferon Type II/*metabolism | 12 | 18.0 |
Protein Structure, Tertiary | 33 | 0.0 |
Recombinant Fusion Proteins/metabolism | 12 | 0.0 |
Transcription, Genetic | 65 | 1.0 |
DNA-Binding Proteins/physiology | 14 | 5.0 |
Transcription Factors/physiology | 3 | 1.0 |
Cell Line, Transformed | 24 | 1.0 |
Hela Cells | 71 | 1.0 |
Interferon Type II/pharmacology | 46 | 7.0 |
Nuclear Proteins/*metabolism | 7 | 1.0 |
Trans-Activators/*genetics | 14 | 4.0 |
Cercopithecus aethiops | 20 | 1.0 |
Down-Regulation | 18 | 0.0 |
Histocompatibility Antigens Class II/*biosynthesis | 3 | 11.0 |
Interferon Type I/*pharmacology | 6 | 12.0 |
Trans-Activators/physiology | 13 | 9.0 |
Cell Nucleus/drug effects/metabolism | 3 | 5.0 |
Cytokines/*pharmacology | 9 | 2.0 |
Epidermal Growth Factor/pharmacology | 8 | 0.0 |
Interferon-gamma, Recombinant/pharmacology | 14 | 9.0 |
Plasminogen Activators/*pharmacology | 2 | 50.0 |
RNA, Messenger/biosynthesis/genetics | 3 | 0.0 |
Interferon-alpha/metabolism | 8 | 36.0 |
Interferon-beta/metabolism | 10 | 52.0 |
Rubulavirus/*pathogenicity/physiology | 2 | 100.0 |
Viral Proteins/metabolism | 4 | 5.0 |
Cell Nucleus/*metabolism | 14 | 3.0 |
Mutagenesis | 11 | 1.0 |
Nuclear Localization Signal | 2 | 2.0 |
Recombinant Fusion Proteins/genetics/metabolism | 12 | 1.0 |
Antigens, CD/analysis | 2 | 0.0 |
Apoptosis | 17 | 0.0 |
Cell Differentiation/drug effects | 10 | 0.0 |
Granulocyte Colony-Stimulating Factor/*pharmacology | 5 | 4.0 |
Neoplasm Proteins/*metabolism | 4 | 0.0 |
Oncogene Proteins, Fusion/*metabolism | 2 | 10.0 |
Recombinant Proteins/pharmacology | 13 | 0.0 |
*Translocation, Genetic | 2 | 0.0 |
Tretinoin/pharmacology | 5 | 1.0 |
Tumor Cells, Cultured/drug effects/metabolism | 3 | 1.0 |
DNA-Binding Proteins/deficiency/genetics/*physiology | 4 | 16.0 |
Follow-Up Studies | 2 | 0.0 |
Interferon-alpha/*pharmacology/therapeutic use | 2 | 20.0 |
Lymphocytes/drug effects/immunology | 2 | 6.0 |
Middle Aged | 27 | 0.0 |
Prognosis | 5 | 0.0 |
Trans-Activators/deficiency/genetics/*physiology | 4 | 26.0 |
DNA-Binding Proteins/genetics/*physiology | 9 | 4.0 |
Gene Expression/physiology | 3 | 0.0 |
Thrombin/*pharmacology | 4 | 3.0 |
Trans-Activators/genetics/*physiology | 10 | 11.0 |
Up-Regulation | 26 | 1.0 |
COS Cells | 22 | 0.0 |
Cell Line, Tumor | 41 | 1.0 |
Cytoplasm/metabolism | 17 | 2.0 |
Epithelial Cells/drug effects/metabolism | 2 | 2.0 |
Mice, SCID | 7 | 0.0 |
Transplantation, Heterologous | 3 | 0.0 |
Amino Acid Substitution | 16 | 1.0 |
Dogs | 2 | 0.0 |
Interferon-alpha/*pharmacology | 40 | 29.0 |
Phosphotyrosine/metabolism | 28 | 6.0 |
Viral Proteins/*metabolism | 3 | 4.0 |
Caspases/metabolism | 10 | 1.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 10 | 5.0 |
Gene Deletion | 6 | 0.0 |
Mice, Knockout | 35 | 1.0 |
Protein p53/*metabolism | 4 | 0.0 |
Trans-Activators/chemistry/genetics/*metabolism | 11 | 14.0 |
2',5'-Oligoadenylate Synthetase/genetics | 3 | 50.0 |
*Gene Expression Regulation, Viral | 4 | 1.0 |
Immediate-Early Proteins/genetics | 2 | 4.0 |
Interferon-alpha/*biosynthesis/genetics | 3 | 75.0 |
Interferon-beta/*biosynthesis/genetics | 2 | 66.0 |
*Protein Biosynthesis | 6 | 1.0 |
*Transcription, Genetic | 21 | 1.0 |
Transgenes | 2 | 0.0 |
Vero Cells | 8 | 3.0 |
Interleukin-2/pharmacology | 6 | 1.0 |
Rabbits | 15 | 0.0 |
Signal Transduction/*immunology | 15 | 3.0 |
Tyrphostins/pharmacology | 10 | 6.0 |
Epithelial Cells/metabolism/virology | 3 | 42.0 |
Interferon-alpha/*biosynthesis | 2 | 11.0 |
Interferon-beta/*biosynthesis | 2 | 40.0 |
Interleukin-6/*biosynthesis | 2 | 1.0 |
Viral Proteins/biosynthesis | 2 | 6.0 |
Chick Embryo | 3 | 0.0 |
Cytokines/pharmacology | 11 | 2.0 |
Neuroblastoma | 3 | 1.0 |
Protein-Tyrosine-Phosphatase/antagonists & inhibitors | 2 | 5.0 |
*Signal Transduction/drug effects | 7 | 7.0 |
*Cell Transformation, Neoplastic | 3 | 0.0 |
Oncogene Proteins, Fusion/genetics/*physiology | 2 | 11.0 |
Luciferases/metabolism | 20 | 3.0 |
Oligonucleotides, Antisense/pharmacology | 5 | 1.0 |
Plasmids/metabolism | 15 | 1.0 |
Sequence Homology, Amino Acid | 22 | 0.0 |
Two-Hybrid System Techniques | 8 | 0.0 |
beta-Galactosidase/metabolism | 3 | 1.0 |
MAP Kinase Signaling System | 5 | 1.0 |
Receptors, Erythropoietin/metabolism | 3 | 9.0 |
Recombinant Proteins/metabolism | 19 | 0.0 |
Serine/*metabolism | 10 | 10.0 |
Stem Cells/metabolism | 3 | 3.0 |
Apoptosis/physiology | 4 | 1.0 |
Cell Division/drug effects/physiology | 5 | 1.0 |
Enzyme Activation/physiology | 5 | 2.0 |
MAP Kinase Kinase 1 | 5 | 3.0 |
Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors | 2 | 4.0 |
Mitogen-Activated Protein Kinases/physiology | 3 | 2.0 |
Protein-Serine-Threonine Kinases/antagonists & inhibitors | 3 | 3.0 |
Receptors, Interleukin-6/metabolism | 2 | 7.0 |
Erythropoietin/pharmacology | 3 | 2.0 |
Genes, myc | 2 | 0.0 |
Neoplasm Proteins/*physiology | 2 | 2.0 |
Promoter Regions (Genetics)/genetics | 9 | 0.0 |
Sequence Deletion | 12 | 0.0 |
Trans-Activation (Genetics)/drug effects | 6 | 2.0 |
English Abstract | 13 | 0.0 |
Epidermal Growth Factor/*pharmacology | 9 | 1.0 |
Protein-Tyrosine Kinase/*physiology | 7 | 5.0 |
Receptor, Epidermal Growth Factor/*physiology | 4 | 2.0 |
Signal Transduction/*physiology | 35 | 2.0 |
DNA-Binding Proteins/chemistry/*metabolism | 15 | 8.0 |
Interferon Type I/*physiology | 5 | 50.0 |
Protein Kinase C/antagonists & inhibitors/*metabolism | 2 | 2.0 |
Trans-Activators/chemistry/*metabolism | 14 | 21.0 |
Antiviral Agents/pharmacology | 7 | 10.0 |
Interferons/pharmacology | 8 | 11.0 |
Ultraviolet Rays | 7 | 1.0 |
Virus Replication | 10 | 1.0 |
DNA-Binding Proteins/deficiency/*metabolism | 2 | 40.0 |
Fibroblasts/metabolism | 12 | 1.0 |
Interferon-alpha/pharmacology | 19 | 20.0 |
Trans-Activators/deficiency/*metabolism | 2 | 50.0 |
*GTP-Binding Proteins | 3 | 5.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 8 | 2.0 |
Mitogen-Activated Protein Kinase 3 | 12 | 1.0 |
Protein-Tyrosine-Phosphatase/metabolism | 3 | 2.0 |
eIF-2 Kinase/metabolism | 2 | 14.0 |
Binding Sites/genetics | 6 | 0.0 |
Sequence Alignment | 9 | 0.0 |
Phosphoserine/metabolism | 5 | 6.0 |
Protein Transport | 6 | 0.0 |
*Sendai virus | 2 | 66.0 |
Staurosporine/pharmacology | 8 | 4.0 |
Viral Proteins/*pharmacology | 2 | 11.0 |
Cytokines/*metabolism | 5 | 1.0 |
Glucose/metabolism | 2 | 0.0 |
Interleukin-6/metabolism/pharmacology | 2 | 20.0 |
Membrane Proteins/metabolism | 3 | 0.0 |
Subcellular Fractions/metabolism | 5 | 1.0 |
Vanadates/pharmacology | 11 | 7.0 |
*beta-Cyclodextrins | 2 | 4.0 |
DNA-Binding Proteins/biosynthesis/genetics/*physiology | 3 | 8.0 |
Fibroblasts | 6 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 38 | 0.0 |
RNA, Messenger/analysis | 14 | 0.0 |
Cell Cycle | 7 | 0.0 |
DNA, Complementary/metabolism | 8 | 0.0 |
Proteins/*chemistry/*metabolism | 2 | 6.0 |
Alternative Splicing | 4 | 0.0 |
Cyclins/*metabolism | 3 | 1.0 |
Integrin alpha5 | 2 | 10.0 |
Protein Isoforms | 4 | 0.0 |
*Protein-Tyrosine Kinase | 12 | 3.0 |
RNA/metabolism | 8 | 1.0 |
Antineoplastic Agents/pharmacology | 7 | 1.0 |
Cells, Cultured/metabolism | 2 | 5.0 |
Fluorescent Antibody Technique, Indirect | 3 | 0.0 |
Green Fluorescent Proteins | 9 | 1.0 |
Immunoblotting | 25 | 1.0 |
Peptides/*metabolism/pharmacology | 2 | 20.0 |
Umbilical Veins/cytology | 6 | 2.0 |
Gene Expression Regulation/*drug effects | 15 | 2.0 |
Antigens, CD34/analysis | 3 | 0.0 |
*Cell Differentiation | 3 | 1.0 |
*Cell Survival | 2 | 5.0 |
Hematopoietic Stem Cells/*physiology | 2 | 1.0 |
Interferon Type II/secretion | 2 | 1.0 |
Interleukin-3/pharmacology | 5 | 1.0 |
Leukemia, Erythroblastic, Acute | 2 | 2.0 |
*Erythropoiesis | 2 | 2.0 |
Granulocyte Colony-Stimulating Factor/pharmacology | 3 | 1.0 |
Mutagenesis, Site-Directed | 31 | 1.0 |
Proto-Oncogene Proteins c-myc/genetics | 2 | 3.0 |
Structure-Activity Relationship | 20 | 0.0 |
Tyrosine | 5 | 4.0 |
Cell Differentiation/physiology | 6 | 1.0 |
Mice, Inbred C57BL | 24 | 0.0 |
Gene Expression Regulation, Viral/drug effects | 2 | 9.0 |
Phosphoproteins/biosynthesis/metabolism | 3 | 42.0 |
Solubility | 5 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 10 | 0.0 |
Trans-Activators/deficiency/genetics/*metabolism | 2 | 33.0 |
Cell Adhesion | 6 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 9 | 0.0 |
Isoenzymes/metabolism | 4 | 0.0 |
Microscopy, Fluorescence | 17 | 0.0 |
Phospholipase C/metabolism | 4 | 1.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors | 5 | 2.0 |
U937 Cells | 11 | 2.0 |
Organ Specificity | 5 | 0.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors/metabolism | 5 | 7.0 |
Interferon Type II/*pharmacology | 62 | 14.0 |
Interleukin-6/*pharmacology | 16 | 7.0 |
Lipopolysaccharides/pharmacology | 6 | 0.0 |
Response Elements | 7 | 3.0 |
Antiviral Agents/*metabolism | 2 | 16.0 |
Enzyme Inhibitors/metabolism | 5 | 2.0 |
Interferon-alpha/*metabolism | 8 | 34.0 |
Mitogen-Activated Protein Kinases/antagonists & inhibitors/*metabolism | 4 | 5.0 |
RNA, Viral/metabolism | 2 | 2.0 |
Ligands | 18 | 0.0 |
Transcription Factors/biosynthesis | 8 | 8.0 |
Cell Division/genetics/immunology | 2 | 7.0 |
Enzyme Activation/immunology | 8 | 6.0 |
Histocompatibility Antigens Class I/biosynthesis | 4 | 8.0 |
Interferon Type II/antagonists & inhibitors/biosynthesis | 2 | 22.0 |
Interleukin-12/physiology | 3 | 23.0 |
Interleukins/*physiology | 2 | 6.0 |
Milk Proteins/metabolism | 3 | 27.0 |
Signal Transduction/genetics/*immunology | 8 | 9.0 |
*Cell Cycle Proteins | 11 | 0.0 |
Cell Differentiation/genetics/immunology | 2 | 2.0 |
DNA-Binding Proteins/antagonists & inhibitors/metabolism | 5 | 23.0 |
Interleukin-6/physiology | 4 | 6.0 |
Protein Binding/immunology | 4 | 2.0 |
Proteins/*genetics/physiology | 2 | 2.0 |
Spleen/immunology/pathology | 2 | 11.0 |
Th1 Cells/immunology/metabolism/pathology | 2 | 40.0 |
Trans-Activators/antagonists & inhibitors/metabolism | 4 | 20.0 |
Genistein/pharmacology | 4 | 3.0 |
*Oxidative Stress | 2 | 0.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors/*metabolism | 2 | 3.0 |
DNA-Binding Proteins/chemistry/*physiology | 2 | 6.0 |
*Gene Expression Regulation, Leukemic | 3 | 3.0 |
Leukemia, Myeloid/*genetics/pathology | 2 | 7.0 |
Protein Processing, Post-Translational | 10 | 1.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors/physiology | 2 | 15.0 |
Trans-Activators/chemistry/*physiology | 2 | 11.0 |
Transcription, Genetic/*physiology | 3 | 1.0 |
Apoptosis/drug effects | 10 | 1.0 |
Immunoenzyme Techniques | 3 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Proto-Oncogene Proteins c-bcl-2/metabolism | 4 | 0.0 |
Receptor, Epidermal Growth Factor/*metabolism | 6 | 0.0 |
Receptor, erbB-2/metabolism | 2 | 1.0 |
DNA-Binding Proteins/*biosynthesis/genetics | 3 | 3.0 |
Fibroblasts/cytology/metabolism | 3 | 1.0 |
*Gene Expression Regulation/drug effects | 5 | 2.0 |
Growth Inhibitors/pharmacology | 9 | 6.0 |
Protein-Tyrosine Kinase/biosynthesis/genetics | 2 | 25.0 |
Proteins/genetics | 11 | 1.0 |
Trans-Activators/*biosynthesis/genetics | 3 | 10.0 |
Apoptosis/*physiology | 4 | 0.0 |
Cell Differentiation | 17 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 13 | 3.0 |
Fusion Proteins, bcr-abl/*genetics/metabolism | 2 | 33.0 |
Trans-Activators/*genetics/metabolism | 12 | 10.0 |
Interleukin-6/*antagonists & inhibitors | 2 | 22.0 |
Protein-Tyrosine-Phosphatase/genetics/*physiology | 2 | 16.0 |
Recombinant Fusion Proteins/physiology | 3 | 1.0 |
Cell Survival/drug effects | 9 | 0.0 |
Hematopoietic Stem Cells/cytology/drug effects/*metabolism | 2 | 33.0 |
Oncogene Proteins, Fusion/genetics/*metabolism/pharmacology | 2 | 50.0 |
Protein Kinases/metabolism | 4 | 0.0 |
Receptors, Fibroblast Growth Factor/*genetics/*metabolism | 3 | 17.0 |
Protein Binding/drug effects | 3 | 0.0 |
Trans-Activators/*drug effects/metabolism | 3 | 50.0 |
Interleukin-13/pharmacology | 2 | 5.0 |
Interleukin-4/pharmacology | 9 | 2.0 |
Microscopy, Confocal | 5 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
Proteins/genetics/*metabolism | 9 | 1.0 |
Adenoviridae/*genetics | 2 | 0.0 |
Interleukin-4/metabolism | 2 | 2.0 |
Killer Cells, Natural/metabolism | 2 | 3.0 |
Monocytes/metabolism | 5 | 1.0 |
T-Lymphocytes/metabolism | 2 | 0.0 |
Cell Separation | 2 | 0.0 |
*Down-Regulation | 4 | 1.0 |
Proteins/*metabolism | 10 | 1.0 |
Receptors, Interleukin/metabolism | 4 | 6.0 |
DNA-Binding Proteins/*genetics/*metabolism | 6 | 4.0 |
Phosphoproteins/*genetics | 6 | 2.0 |
*Trans-Activation (Genetics) | 17 | 2.0 |
DNA-Binding Proteins/*antagonists & inhibitors/metabolism | 8 | 26.0 |
Drug Antagonism | 3 | 6.0 |
Hamsters | 13 | 0.0 |
Interleukin-6/*antagonists & inhibitors/pharmacology | 3 | 50.0 |
Peptides/pharmacology | 3 | 1.0 |
Protein-Tyrosine-Phosphatase/*physiology | 2 | 7.0 |
Trans-Activators/*antagonists & inhibitors/metabolism | 8 | 40.0 |
Cell Fractionation | 3 | 1.0 |
Genes, Reporter/genetics | 5 | 1.0 |
Ligases/metabolism | 2 | 3.0 |
Proteins/chemistry/*metabolism | 2 | 2.0 |
Ubiquitins/*metabolism | 2 | 1.0 |
Alanine/chemistry | 2 | 2.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
Cytokines/metabolism | 14 | 3.0 |
DNA/*metabolism | 11 | 2.0 |
DNA-Binding Proteins/antagonists & inhibitors/*metabolism | 6 | 22.0 |
Growth Substances/metabolism | 3 | 2.0 |
Insects | 5 | 2.0 |
Trans-Activators/antagonists & inhibitors/*metabolism | 9 | 39.0 |
src Homology Domains | 15 | 2.0 |
Gene Expression Regulation/*physiology | 3 | 0.0 |
Receptors, Interleukin-6/*physiology | 2 | 40.0 |
Antineoplastic Agents/metabolism/*pharmacology | 2 | 7.0 |
Biopsy | 6 | 0.0 |
Cell Cycle/physiology | 2 | 0.0 |
Interferon Type II/genetics/*pharmacology | 3 | 100.0 |
Biological Markers/analysis | 3 | 0.0 |
Prospective Studies | 2 | 0.0 |
DNA-Binding Proteins/analysis | 6 | 7.0 |
Leptin/*pharmacology | 2 | 6.0 |
*Receptors, Cell Surface | 2 | 0.0 |
Trans-Activators/analysis | 4 | 13.0 |
*Cell Transformation, Viral | 2 | 1.0 |
Tissue Distribution | 4 | 0.0 |
Transcription Factors/*genetics/*physiology | 2 | 7.0 |
Cysteine | 2 | 1.0 |
Interferons/*pharmacology/therapeutic use | 2 | 66.0 |
Virus Replication/drug effects | 2 | 0.0 |
Cell Cycle/drug effects | 3 | 0.0 |
Doxorubicin/pharmacology | 2 | 0.0 |
Gene Expression Profiling | 14 | 1.0 |
Gene Expression Regulation, Neoplastic | 11 | 0.0 |
Transcription Factors/biosynthesis/genetics/*physiology | 2 | 8.0 |
Amino Acid Motifs | 7 | 0.0 |
Cell Line, Transformed/drug effects | 2 | 14.0 |
Genetic Complementation Test | 4 | 0.0 |
Antineoplastic Agents/*therapeutic use | 4 | 1.0 |
Electrophoresis, Polyacrylamide Gel | 15 | 0.0 |
Interferon-alpha/*therapeutic use | 2 | 3.0 |
Mice, Inbred NOD | 2 | 0.0 |
Neoplasm Transplantation | 5 | 0.0 |
Stem Cell Factor/pharmacology | 3 | 2.0 |
Mice, Transgenic | 13 | 0.0 |
Phenotype | 10 | 0.0 |
Signal Transduction/genetics/immunology | 7 | 9.0 |
Drug Resistance | 2 | 0.0 |
Human Growth Hormone/*pharmacology | 2 | 5.0 |
Liver/drug effects/metabolism | 3 | 4.0 |
Antigens, CD3/immunology | 2 | 0.0 |
In Vitro | 11 | 0.0 |
Interferon Type II/genetics | 2 | 2.0 |
Interferon-alpha/*immunology | 2 | 50.0 |
Lymphocyte Activation | 10 | 0.0 |
Organ Culture Techniques | 2 | 0.0 |
Interleukin-8/metabolism | 2 | 1.0 |
Microglia/*metabolism | 2 | 11.0 |
Tumor Necrosis Factor-alpha/genetics/metabolism | 3 | 5.0 |
2',5'-Oligoadenylate Synthetase/*metabolism | 2 | 50.0 |
Interferon Alfa-2b/*pharmacology | 3 | 13.0 |
*Genes, MHC Class II | 4 | 1.0 |
Active Transport, Cell Nucleus/drug effects | 4 | 11.0 |
Fibroblast Growth Factors/*pharmacology | 2 | 4.0 |
Cytotoxicity, Immunologic | 3 | 0.0 |
DNA Primers/chemistry | 3 | 0.0 |
Interleukin-2/*pharmacology | 5 | 1.0 |
Adjuvants, Immunologic/*pharmacology | 2 | 1.0 |
Anti-HIV Agents/*pharmacology | 2 | 1.0 |
CHO Cells | 5 | 0.0 |
*Drosophila Proteins | 2 | 0.0 |
Macrophages/drug effects/*metabolism | 2 | 3.0 |
Membrane Glycoproteins/physiology | 2 | 1.0 |
Receptors, Cell Surface/physiology | 3 | 2.0 |
Transcription Factor AP-1/metabolism | 6 | 2.0 |
Protein-Tyrosine Kinase/physiology | 6 | 5.0 |
Cysteine Proteinase Inhibitors/pharmacology | 5 | 2.0 |
Leupeptins/pharmacology | 5 | 3.0 |
Proteasome Endopeptidase Complex | 12 | 2.0 |
*Ubiquitins/*analogs & derivatives | 3 | 60.0 |
Interferons/physiology | 2 | 8.0 |
DNA Primers/genetics | 7 | 0.0 |
Encephalomyocarditis virus/immunology | 2 | 100.0 |
Genetic Vectors | 4 | 0.0 |
Mice, Nude | 4 | 0.0 |
Consensus Sequence | 9 | 1.0 |
DNA/genetics/metabolism | 8 | 2.0 |
DNA-Binding Proteins/*chemistry/*metabolism | 3 | 5.0 |
Macromolecular Substances | 12 | 0.0 |
Trans-Activators/*chemistry/*metabolism | 3 | 16.0 |
Chemokines, CXC/*genetics/metabolism | 3 | 50.0 |
DNA-Binding Proteins/genetics/physiology | 4 | 5.0 |
Interferon Type II/metabolism/pharmacology | 4 | 28.0 |
Interferon-alpha/metabolism/pharmacology | 3 | 42.0 |
Trans-Activators/genetics/physiology | 6 | 22.0 |
Cytopathogenic Effect, Viral | 7 | 4.0 |
Genes, Viral | 4 | 1.0 |
Macaca mulatta | 3 | 0.0 |
RNA, Viral/biosynthesis | 3 | 6.0 |
Immunohistochemistry/methods | 3 | 0.0 |
Keratinocytes/chemistry | 2 | 11.0 |
Protein-Tyrosine Kinase/*analysis | 2 | 6.0 |
Trans-Activators/*analysis | 2 | 8.0 |
Fibroblast Growth Factors/metabolism | 2 | 3.0 |
*Mutation | 7 | 0.0 |
*Adaptor Proteins, Signal Transducing | 6 | 0.0 |
Mitogen-Activated Protein Kinases/*physiology | 3 | 4.0 |
Signal Transduction/immunology | 11 | 3.0 |
Protein Binding/genetics/immunology | 4 | 4.0 |
Receptors, Interleukin/*physiology | 5 | 20.0 |
Angiotensin II/*pharmacology | 2 | 1.0 |
DNA-Binding Proteins/*biosynthesis | 5 | 4.0 |
Survival Rate | 3 | 0.0 |
Trans-Activators/*biosynthesis | 4 | 7.0 |
DNA-Binding Proteins/immunology | 2 | 9.0 |
Gene Expression Regulation/*immunology | 5 | 4.0 |
Promoter Regions (Genetics)/immunology | 8 | 11.0 |
Proteins/genetics/*immunology | 2 | 25.0 |
Trans-Activators/immunology | 2 | 14.0 |
Vesicular stomatitis-Indiana virus/immunology | 2 | 28.0 |
Interferons/*pharmacology | 8 | 10.0 |
Macrophages/metabolism | 7 | 2.0 |
Receptors, Interferon/physiology | 4 | 57.0 |
*Immediate-Early Proteins | 2 | 0.0 |
*Apoptosis/drug effects | 3 | 2.0 |
Drug Synergism | 20 | 1.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors/*physiology | 2 | 20.0 |
Phosphotyrosine/analysis | 3 | 5.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 6 | 1.0 |
Codon | 3 | 0.0 |
Monocytes/drug effects/*metabolism | 2 | 1.0 |
*Promoter Regions (Genetics) | 18 | 0.0 |
Biological Transport | 13 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism/physiology | 2 | 12.0 |
Mitogen-Activated Protein Kinase 8 | 4 | 5.0 |
Enzyme Inhibitors/*pharmacology | 5 | 0.0 |
Nitric-Oxide Synthase/metabolism | 5 | 4.0 |
Cyclins/genetics | 3 | 2.0 |
Embryo | 6 | 1.0 |
Fibroblasts/chemistry | 2 | 4.0 |
Herpesvirus 4, Human | 2 | 1.0 |
Phosphoproteins/genetics | 4 | 3.0 |
Regulatory Sequences, Nucleic Acid | 9 | 1.0 |
Transcription Factors/genetics | 4 | 0.0 |
Gene Therapy/*methods | 2 | 0.0 |
Interferon Type II/*genetics | 3 | 5.0 |
Macrophages/*immunology | 3 | 1.0 |
Transduction, Genetic | 4 | 1.0 |
Carcinoma, Squamous Cell/*metabolism/pathology | 2 | 2.0 |
Disease Progression | 6 | 0.0 |
Chromatin Immunoprecipitation | 2 | 5.0 |
Protein-Serine-Threonine Kinases/genetics/*metabolism | 2 | 0.0 |
Transcription, Genetic/*genetics | 2 | 1.0 |
Animals, Genetically Modified | 2 | 0.0 |
RNA Interference | 3 | 1.0 |
Tumor Necrosis Factor-alpha/*pharmacology | 5 | 0.0 |
Receptors, Interferon/genetics/immunology | 2 | 50.0 |
Transcription Factors/*genetics | 4 | 0.0 |
Hematopoietic Stem Cells/cytology | 2 | 2.0 |
Interleukin-3/*pharmacology | 2 | 1.0 |
Interleukin-5/*pharmacology | 2 | 6.0 |
Apoptosis/*drug effects/physiology | 3 | 2.0 |
DNA-Binding Proteins/drug effects/metabolism | 3 | 11.0 |
Interleukin-9/*pharmacology | 2 | 25.0 |
Transcription, Genetic/drug effects/physiology | 2 | 5.0 |
Receptors, Interferon/*metabolism | 7 | 25.0 |
Receptors, Fibroblast Growth Factor/genetics/*metabolism | 3 | 8.0 |
Cattle | 4 | 0.0 |
Haplorhini | 2 | 0.0 |
Flavonoids/*pharmacology | 3 | 3.0 |
Intercellular Adhesion Molecule-1/*genetics | 2 | 8.0 |
Oligonucleotide Probes | 3 | 0.0 |
RNA, Messenger/genetics | 6 | 0.0 |
Transcription, Genetic/*drug effects | 6 | 1.0 |
Antiviral Agents/*pharmacology | 10 | 6.0 |
Eukaryotic Initiation Factor-2/metabolism | 2 | 6.0 |
Conserved Sequence | 9 | 0.0 |
Mitogen-Activated Protein Kinase 1/*metabolism | 2 | 1.0 |
Substrate Specificity | 3 | 0.0 |
Protein-Tyrosine Kinase/*immunology | 2 | 13.0 |
Receptors, CCR5/immunology | 2 | 10.0 |
Signal Transduction/drug effects/*immunology | 5 | 13.0 |
T-Lymphocytes/*immunology | 4 | 0.0 |
Ribonucleases/metabolism | 4 | 3.0 |
Tumor Necrosis Factor-alpha/metabolism | 3 | 0.0 |
Methylation | 4 | 0.0 |
Carrier Proteins/genetics/*metabolism | 3 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 4 | 1.0 |
Repressor Proteins/genetics/*metabolism | 3 | 1.0 |
Antigen Presentation | 2 | 0.0 |
Immunity, Natural | 5 | 2.0 |
Killer Cells, Natural/immunology | 2 | 0.0 |
T-Lymphocytes/immunology | 2 | 0.0 |
DNA-Binding Proteins/biosynthesis/genetics | 2 | 2.0 |
Interferon-alpha/biosynthesis/genetics | 2 | 40.0 |
Phosphoproteins/biosynthesis/genetics | 2 | 11.0 |
Cycloheximide/pharmacology | 13 | 1.0 |
Viral Proteins/*physiology | 2 | 6.0 |
Cell Transformation, Neoplastic/*metabolism | 2 | 5.0 |
Biological Transport/drug effects | 6 | 2.0 |
Chloramphenicol O-Acetyltransferase/genetics/metabolism | 3 | 1.0 |
Muscle, Smooth, Vascular/cytology/drug effects/metabolism | 2 | 28.0 |
Recombinant Fusion Proteins/drug effects/genetics/metabolism | 2 | 10.0 |
Acute-Phase Proteins/metabolism | 8 | 12.0 |
Carcinoma, Hepatocellular | 12 | 3.0 |
Enhancer Elements (Genetics)/genetics | 2 | 2.0 |
Liver Neoplasms | 11 | 3.0 |
Viral Matrix Proteins/genetics/*metabolism | 2 | 10.0 |
Virus Latency | 2 | 3.0 |
Chimeric Proteins/metabolism | 3 | 1.0 |
Phosphoproteins/genetics/metabolism | 4 | 5.0 |
Chronic Disease | 2 | 0.0 |
Infant, Newborn | 4 | 0.0 |
Interleukin-13/*pharmacology | 3 | 6.0 |
Interleukin-4/*pharmacology | 7 | 3.0 |
Brefeldin A/pharmacology | 2 | 2.0 |
Catalysis | 4 | 0.0 |
Endoplasmic Reticulum/metabolism | 2 | 0.0 |
Glycosylation | 2 | 0.0 |
Immunoprecipitation | 2 | 0.0 |
Lysine/chemistry | 3 | 3.0 |
Protein Conformation | 8 | 0.0 |
Receptors, Fibroblast Growth Factor/*metabolism | 2 | 3.0 |
Tyrosine/chemistry | 8 | 6.0 |
Drug Therapy, Combination | 3 | 0.0 |
Leukemia, Myeloid/drug therapy/*pathology | 2 | 28.0 |
Treatment Outcome | 3 | 0.0 |
Tretinoin/*pharmacology/therapeutic use | 2 | 14.0 |
DNA-Binding Proteins/chemistry/genetics/metabolism | 2 | 6.0 |
Recombinant Proteins/genetics/metabolism | 4 | 0.0 |
Trans-Activators/chemistry/genetics/metabolism | 2 | 18.0 |
Cell Movement/drug effects | 2 | 0.0 |
DNA-Binding Proteins | 2 | 2.0 |
Fluorescent Antibody Technique | 5 | 0.0 |
Trans-Activators | 3 | 7.0 |
Antibodies/pharmacology | 2 | 0.0 |
Genes, fos/genetics | 2 | 4.0 |
Killer Cells, Natural/*immunology/metabolism | 3 | 7.0 |
DNA-Binding Proteins/*genetics | 12 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
DNA-Binding Proteins/biosynthesis/metabolism | 3 | 30.0 |
Receptors, Retinoic Acid/metabolism | 2 | 2.0 |
eIF-2 Kinase/*genetics | 2 | 20.0 |
Luciferases/genetics | 5 | 1.0 |
Cysteine Endopeptidases/*metabolism | 8 | 3.0 |
HL-60 Cells | 4 | 0.0 |
Interleukin-6/*metabolism | 6 | 5.0 |
Multienzyme Complexes/*metabolism | 5 | 3.0 |
Interferons/*therapeutic use | 3 | 13.0 |
Genotype | 2 | 0.0 |
Interferons/*metabolism | 6 | 33.0 |
RNA, Double-Stranded/*metabolism | 3 | 42.0 |
Retroviridae/genetics | 2 | 0.0 |
Intercellular Adhesion Molecule-1/biosynthesis | 4 | 4.0 |
Arginine | 2 | 2.0 |
DNA-Binding Proteins/*chemistry/genetics/*metabolism | 4 | 7.0 |
Models, Molecular | 12 | 0.0 |
Trans-Activators/*chemistry/genetics/*metabolism | 4 | 19.0 |
Dose-Response Relationship, Immunologic | 3 | 0.0 |
Gene Expression Regulation, Neoplastic/*immunology | 2 | 13.0 |
Interferon Type II/metabolism/*physiology | 2 | 66.0 |
Signal Transduction/*genetics/*immunology | 2 | 22.0 |
Signal Transduction/*drug effects/physiology | 5 | 8.0 |
Antioxidants/pharmacology | 4 | 2.0 |
*I-kappa B | 2 | 1.0 |
Immediate-Early Proteins/genetics/*metabolism | 2 | 3.0 |
Acute-Phase Proteins/genetics | 2 | 28.0 |
Down-Regulation/drug effects | 4 | 1.0 |
Interleukin-1/*pharmacology | 3 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/metabolism | 3 | 2.0 |
Protein-Tyrosine-Phosphatase/antagonists & inhibitors/metabolism | 2 | 14.0 |
Luminescent Proteins/genetics/metabolism | 3 | 1.0 |
Sendai virus/*pathogenicity | 3 | 100.0 |
Viral Proteins/*chemistry/genetics/metabolism | 2 | 50.0 |
Caco-2 Cells | 5 | 1.0 |
Enzyme Activation/drug effects/physiology | 2 | 3.0 |
Oligonucleotide Probes/genetics | 2 | 1.0 |
Protein Structure, Quaternary | 2 | 1.0 |
*Receptors, Cytoplasmic and Nuclear | 2 | 2.0 |
Recombinant Fusion Proteins/chemistry/genetics/metabolism | 2 | 1.0 |
Chloramphenicol O-Acetyltransferase/metabolism | 2 | 1.0 |
Child, Preschool | 2 | 0.0 |
Infant | 3 | 0.0 |
T-Lymphocytes/immunology/metabolism | 4 | 3.0 |
T-Lymphocytes, Cytotoxic/immunology | 2 | 0.0 |
Mice, Inbred ICR | 3 | 1.0 |
Interferon Type II/physiology | 3 | 3.0 |
Interleukin-15/physiology | 2 | 33.0 |
Lymphocyte Activation/genetics | 3 | 3.0 |
Interleukin-10/*metabolism | 2 | 6.0 |
Liver/*metabolism | 2 | 0.0 |
RNA, Messenger | 4 | 0.0 |
Acute-Phase Reaction/genetics | 2 | 40.0 |
Interferon Type II/*antagonists & inhibitors/pharmacology | 3 | 100.0 |
Receptors, Interleukin-6/physiology | 2 | 22.0 |
Fatty Acids, Unsaturated/pharmacology | 2 | 3.0 |
Neoplasm Proteins/metabolism | 2 | 0.0 |
Phosphotyrosine/*biosynthesis | 2 | 66.0 |
Receptors, Interferon/drug effects/metabolism | 2 | 50.0 |
NF-kappa B/*physiology | 3 | 3.0 |
Tumor Necrosis Factor-alpha/physiology | 2 | 1.0 |
DNA-Binding Proteins/metabolism/*physiology | 11 | 9.0 |
Lipopolysaccharides/*pharmacology | 4 | 0.0 |
Repressor Proteins/metabolism | 6 | 3.0 |
Trans-Activators/metabolism/*physiology | 9 | 15.0 |
Transfection/immunology | 2 | 4.0 |
1-(5-Isoquinolinesulfonyl)-2-methylpiperazine/pharmacology | 3 | 9.0 |
Receptors, Antigen, T-Cell/*metabolism | 2 | 1.0 |
Receptors, IgG/metabolism | 3 | 4.0 |
Drug Combinations | 3 | 0.0 |
Interferon-gamma, Recombinant/*pharmacology | 18 | 13.0 |
Interleukin-3/metabolism | 2 | 6.0 |
Recombination, Genetic | 2 | 0.0 |
Proteins/analysis | 2 | 1.0 |
Trans-Activation (Genetics)/*physiology | 2 | 1.0 |
Mice, Mutant Strains | 5 | 0.0 |
Phosphoproteins/genetics/*metabolism | 5 | 3.0 |
Cell Cycle/genetics | 2 | 1.0 |
Cytokines/genetics | 2 | 1.0 |
DNA, Complementary | 3 | 0.0 |
Cervix Neoplasms | 2 | 8.0 |
Phosphorylation/radiation effects | 2 | 6.0 |
Nuclear Proteins/metabolism | 13 | 1.0 |
Plasmids | 3 | 0.0 |
PC12 Cells | 5 | 1.0 |
Receptor Protein-Tyrosine Kinases/genetics/*metabolism | 3 | 2.0 |
*Cysteine Endopeptidases | 2 | 4.0 |
Breast Neoplasms/*metabolism | 2 | 0.0 |
Cysteine Endopeptidases/metabolism | 3 | 1.0 |
Multienzyme Complexes/metabolism | 3 | 1.0 |
Adolescent | 7 | 0.0 |
Interferon Type II/*immunology/pharmacology | 3 | 60.0 |
Thymus Gland/cytology | 2 | 2.0 |
Phosphoserine | 2 | 50.0 |
Trans-Activation (Genetics)/*drug effects | 6 | 6.0 |
Corticotropin/secretion | 2 | 3.0 |
Gene Expression/drug effects/immunology | 2 | 5.0 |
Pro-Opiomelanocortin/genetics | 2 | 11.0 |
RNA, Messenger/drug effects/metabolism | 4 | 2.0 |
Enhancer Elements (Genetics) | 3 | 0.0 |
Interferons/metabolism | 8 | 34.0 |
Receptor Cross-Talk | 2 | 5.0 |
Gene Expression Regulation/*genetics | 2 | 1.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Receptors, Cell Surface/*metabolism | 5 | 0.0 |
Gene Expression Regulation/physiology | 3 | 1.0 |
Lipopolysaccharides/*metabolism | 2 | 1.0 |
Macrophages/*metabolism | 5 | 2.0 |
Tumor Necrosis Factor-alpha/*metabolism | 2 | 0.0 |
Gene Expression Regulation, Enzymologic | 6 | 0.0 |
Anti-Inflammatory Agents, Non-Steroidal/*pharmacology | 2 | 1.0 |
Epidermal Growth Factor/*metabolism | 2 | 0.0 |
Indomethacin/*pharmacology | 2 | 5.0 |
Tissue Distribution/drug effects | 2 | 25.0 |
Glutathione Transferase/genetics | 2 | 0.0 |
Recombinant Fusion Proteins/biosynthesis | 8 | 1.0 |
*Transcription, Genetic/drug effects | 4 | 3.0 |
DNA-Binding Proteins/*antagonists & inhibitors/genetics/metabolism | 3 | 37.0 |
Fibroblast Growth Factor 2/pharmacology | 2 | 0.0 |
Membrane Glycoproteins/chemistry/*metabolism | 2 | 6.0 |
Oligodeoxyribonucleotides | 15 | 1.0 |
Trans-Activators/*antagonists & inhibitors/genetics/metabolism | 3 | 37.0 |
Protein Kinase Inhibitors | 4 | 3.0 |
Cell Division/drug effects/*physiology | 2 | 7.0 |
Thymidine/metabolism | 3 | 0.0 |
*Intercellular Signaling Peptides and Proteins | 3 | 0.0 |
Interleukin-4/*genetics/metabolism | 2 | 66.0 |
Receptors, Interleukin/biosynthesis | 2 | 12.0 |
Protein Synthesis Inhibitors/pharmacology | 5 | 1.0 |
Trans-Activators/antagonists & inhibitors/*metabolism/physiology | 2 | 50.0 |
Nuclear Proteins/*genetics/metabolism | 2 | 1.0 |
Thrombopoietin/*pharmacology | 7 | 7.0 |
Immunosuppressive Agents/*pharmacology | 3 | 1.0 |
DNA/genetics | 2 | 0.0 |
Enzyme Induction/drug effects | 3 | 0.0 |
Interferon Type I, Recombinant/pharmacology | 4 | 12.0 |
Transcription Factors/genetics/*metabolism | 7 | 0.0 |
Trans-Activators/*analysis/metabolism | 2 | 100.0 |
Forskolin/pharmacology | 2 | 0.0 |
Protein Processing, Post-Translational/drug effects | 4 | 3.0 |
Protein-Serine-Threonine Kinases/metabolism | 9 | 1.0 |
Transcription Factors/chemistry/*metabolism | 4 | 2.0 |
DNA, Neoplasm/metabolism | 5 | 3.0 |
Interleukin-6/pharmacology | 12 | 4.0 |
Lymphokines/pharmacology | 4 | 2.0 |
Tumor Cells, Cultured/*drug effects/metabolism | 2 | 7.0 |
Cell Division/*drug effects | 5 | 1.0 |
Cyclins/genetics/*metabolism | 2 | 2.0 |
DNA/biosynthesis | 4 | 0.0 |
Up-Regulation/drug effects | 6 | 1.0 |
Crystallography, X-Ray | 2 | 0.0 |
Protein Binding/genetics | 2 | 0.0 |
Signal Transduction/*genetics | 3 | 2.0 |
COS Cells/metabolism | 2 | 3.0 |
Prolactin/metabolism | 2 | 3.0 |
DNA-Binding Proteins/analysis/metabolism | 2 | 9.0 |
Trans-Activators/analysis/metabolism | 2 | 50.0 |
Cell Division/physiology | 5 | 0.0 |
Muscle, Smooth, Vascular/cytology/drug effects/*metabolism | 2 | 7.0 |
Oligodeoxyribonucleotides/genetics | 2 | 2.0 |
Response Elements/physiology | 2 | 6.0 |
Cytokines/blood | 2 | 0.0 |
GTP-Binding Proteins/*metabolism | 4 | 1.0 |
Cytoplasm/drug effects/*metabolism | 2 | 33.0 |
Gene Expression Regulation/drug effects/*physiology | 4 | 5.0 |
Platelet-Derived Growth Factor/pharmacology | 4 | 2.0 |
*Adaptor Proteins, Vesicular Transport | 4 | 1.0 |
Bone Marrow Cells | 3 | 0.0 |
DNA-Binding Proteins/genetics/*immunology | 2 | 14.0 |
Gene Expression Regulation, Neoplastic/immunology | 3 | 10.0 |
*Proto-Oncogene Proteins c-bcl-2 | 2 | 0.0 |
Trans-Activators/genetics/*immunology | 2 | 50.0 |
Up-Regulation/immunology | 4 | 2.0 |
Breast Neoplasms/*metabolism/pathology | 3 | 1.0 |
DNA-Binding Proteins/biosynthesis/*metabolism | 5 | 8.0 |
Receptors, Retinoic Acid/*metabolism | 2 | 3.0 |
Trans-Activators/biosynthesis/*metabolism | 5 | 33.0 |
Tretinoin/*pharmacology | 9 | 2.0 |
DNA-Binding Proteins/biosynthesis | 3 | 3.0 |
Interferon Alfa-2a/*pharmacology | 2 | 18.0 |
Melanoma/*metabolism/pathology | 2 | 5.0 |
Receptors, Interferon/biosynthesis | 3 | 60.0 |
Trans-Activators/biosynthesis | 2 | 5.0 |
*Tumor Suppressor Proteins | 3 | 0.0 |
Growth Inhibitors/*pharmacology | 4 | 2.0 |
Peptides/*pharmacology | 4 | 1.0 |
Gene Expression Regulation/immunology | 7 | 4.0 |
*Growth Inhibitors | 2 | 3.0 |
*Interleukin-6 | 3 | 0.0 |
*Lymphokines | 2 | 4.0 |
Nuclear Proteins/genetics/metabolism | 2 | 1.0 |
Pregnancy | 6 | 0.0 |
B-Lymphocytes/*immunology | 3 | 0.0 |
Neoplasm Proteins/genetics | 2 | 0.0 |
Interferon-beta/*metabolism | 3 | 25.0 |
Viral Structural Proteins/*metabolism | 5 | 71.0 |
Exons | 2 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Protein Structure, Secondary | 3 | 0.0 |
Conserved Sequence/genetics | 2 | 1.0 |
Molecular Weight | 6 | 0.0 |
Multigene Family | 4 | 0.0 |
Cytokines/biosynthesis/genetics | 2 | 3.0 |
HT29 Cells | 3 | 1.0 |
Trans-Activation (Genetics)/immunology | 5 | 20.0 |
Cell Nucleus/*physiology | 4 | 14.0 |
Enzyme Induction | 5 | 0.0 |
Proto-Oncogene Proteins c-fos/metabolism | 3 | 2.0 |
DNA-Binding Proteins/*antagonists & inhibitors/*metabolism | 2 | 25.0 |
Interferon Type II/*antagonists & inhibitors/*physiology | 2 | 100.0 |
Mycobacterium tuberculosis/growth & development/*immunology | 2 | 40.0 |
Trans-Activators/*antagonists & inhibitors/*metabolism | 2 | 40.0 |
Transcription Factors/antagonists & inhibitors/metabolism | 2 | 15.0 |
Tyrosine/antagonists & inhibitors/metabolism | 2 | 22.0 |
HLA-DR Antigens/*metabolism | 2 | 3.0 |
Intercellular Adhesion Molecule-1/*metabolism | 2 | 3.0 |
Protein Kinase C/metabolism | 4 | 0.0 |
Protein-Tyrosine-Phosphatase/*metabolism | 6 | 4.0 |
Trans-Activators/antagonists & inhibitors/biosynthesis/genetics | 2 | 40.0 |
Urinary Plasminogen Activator/*pharmacology | 2 | 25.0 |
DNA-Binding Proteins/*biosynthesis/metabolism | 2 | 13.0 |
Evolution, Molecular | 2 | 0.0 |
Models, Genetic | 4 | 0.0 |
Phylogeny | 5 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Trans-Activators/*biosynthesis/genetics/metabolism | 2 | 50.0 |
*Viral Proteins | 3 | 1.0 |
Gene Expression Regulation, Neoplastic/*drug effects | 3 | 1.0 |
Protein-Tyrosine-Phosphatase/physiology | 4 | 17.0 |
RNA, Neoplasm/biosynthesis | 2 | 1.0 |
Retinoblastoma Protein/metabolism | 2 | 0.0 |
Cell Differentiation/immunology | 2 | 0.0 |
DNA-Binding Proteins/*metabolism/physiology | 3 | 7.0 |
Trans-Activators/*metabolism/physiology | 2 | 12.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 7 | 2.0 |
src-Family Kinases/*metabolism | 4 | 2.0 |
Drosophila | 2 | 0.0 |
Fungal Proteins/metabolism | 2 | 1.0 |
Point Mutation | 5 | 0.0 |
*Gene Expression Profiling | 3 | 0.0 |
*Oligonucleotide Array Sequence Analysis | 3 | 1.0 |
Receptors, Cytokine/*metabolism | 5 | 5.0 |
Chromatin/metabolism | 3 | 1.0 |
Histone Deacetylases/*metabolism | 2 | 1.0 |
Hydroxamic Acids/pharmacology | 3 | 1.0 |
Cell Adhesion/drug effects | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay/methods | 2 | 0.0 |
HIV-1 | 2 | 1.0 |
Cell Transformation, Viral | 2 | 0.0 |
Leukocytes, Mononuclear/metabolism | 2 | 0.0 |
Mitogens/pharmacology | 2 | 0.0 |
T-Lymphocytes/*metabolism | 8 | 2.0 |
Calcium/metabolism | 2 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Cell Lineage | 2 | 0.0 |
Clone Cells | 5 | 0.0 |
*Up-Regulation | 3 | 1.0 |
Epithelial Cells/metabolism | 5 | 1.0 |
Th1 Cells/immunology | 4 | 2.0 |
Lipoproteins, LDL/*metabolism | 2 | 1.0 |
Reactive Oxygen Species/*metabolism | 2 | 1.0 |
Protein Kinase C/antagonists & inhibitors | 2 | 1.0 |
T-Lymphocytes/drug effects/*immunology | 2 | 1.0 |
DNA-Binding Proteins/analysis/*metabolism | 2 | 10.0 |
Interleukin-12/*pharmacology | 3 | 6.0 |
Protein-Tyrosine Kinase | 3 | 8.0 |
DNA-Binding Proteins/immunology/*metabolism | 4 | 16.0 |
Interferon Type II | 2 | 11.0 |
Trans-Activators/immunology/*metabolism | 4 | 36.0 |
Models, Animal | 2 | 0.0 |
*Neoplasm Proteins | 5 | 0.0 |
Platelet Aggregation Inhibitors/pharmacology | 2 | 3.0 |
*Receptors, Cytokine | 2 | 1.0 |
Cyclosporine/pharmacology | 2 | 0.0 |
Interleukin-2/*physiology | 2 | 2.0 |
*MAP Kinase Kinase Kinase 1 | 2 | 1.0 |
*Mitogen-Activated Protein Kinases | 4 | 1.0 |
DNA/antagonists & inhibitors/metabolism | 2 | 100.0 |
Down-Regulation/*immunology | 2 | 3.0 |
Response Elements/immunology | 2 | 12.0 |
Transcription, Genetic/immunology | 2 | 2.0 |
Transcription Factors/*physiology | 4 | 0.0 |
Lymphocytes/immunology | 2 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 3 | 1.0 |
Interleukin-15/pharmacology | 3 | 13.0 |
Recombinant Proteins | 3 | 0.0 |
Fibrosarcoma | 2 | 4.0 |
Karyopherins/metabolism | 2 | 9.0 |
Luminescent Proteins/genetics | 3 | 1.0 |
Signal Transduction/drug effects/genetics | 3 | 8.0 |
Th2 Cells/immunology | 2 | 1.0 |
G1 Phase/drug effects | 2 | 1.0 |
Microtubule-Associated Proteins/*metabolism | 2 | 1.0 |
Tumor Cells, Cultured/drug effects | 2 | 0.0 |
DNA-Binding Proteins/metabolism/physiology | 3 | 15.0 |
DNA-Binding Proteins/*biosynthesis/*metabolism | 2 | 40.0 |
Transcription Factors/*biosynthesis | 3 | 2.0 |
In Situ Hybridization, Fluorescence | 4 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 3 | 0.0 |
Breast Neoplasms | 2 | 0.0 |
Antibodies, Monoclonal | 5 | 0.0 |
Intercellular Adhesion Molecule-1/metabolism | 3 | 1.0 |
Heterozygote | 2 | 0.0 |
Homozygote | 2 | 0.0 |
*Point Mutation | 2 | 0.0 |
Phosphoproteins/biosynthesis | 2 | 5.0 |
Signal Transduction/drug effects/immunology | 2 | 4.0 |
Interferon-alpha/biosynthesis | 2 | 8.0 |
Interleukin-12/biosynthesis | 2 | 2.0 |
Epithelial Cells/cytology | 2 | 2.0 |
Histocompatibility Antigens Class I/*biosynthesis | 2 | 5.0 |
Lung/cytology | 2 | 3.0 |
Virus Activation | 2 | 3.0 |
Tyrosine/*chemistry | 2 | 15.0 |
Trans-Activators/*genetics/*metabolism | 2 | 5.0 |
Transforming Growth Factor beta/*metabolism | 2 | 0.0 |
DNA, Complementary/chemistry | 2 | 1.0 |
Major Histocompatibility Complex/*genetics | 2 | 1.0 |
Microinjections | 2 | 0.0 |
Interferon Type II/*genetics/pharmacology | 2 | 50.0 |
Virus Replication/*drug effects | 2 | 1.0 |
Hydrogen Peroxide/pharmacology | 2 | 0.0 |
Oxidants/pharmacology | 2 | 3.0 |
Protein-Tyrosine Kinase/metabolism/*physiology | 2 | 7.0 |
*Trans-Activation (Genetics)/drug effects | 2 | 4.0 |
Transcription Factors/antagonists & inhibitors/*metabolism | 2 | 13.0 |
Electrophoresis | 3 | 1.0 |
K562 Cells | 3 | 0.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Peptide Fragments/metabolism | 3 | 0.0 |
Carcinoma, Squamous Cell | 2 | 1.0 |
Transforming Growth Factor beta/*pharmacology | 3 | 0.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
*Active Transport, Cell Nucleus | 2 | 5.0 |
Arginine/metabolism | 2 | 3.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 2 | 1.0 |
RNA, Small Interfering/metabolism | 2 | 1.0 |
Proteins/*physiology | 2 | 1.0 |
Interleukin-6/*physiology | 2 | 2.0 |
Protein p53/physiology | 2 | 2.0 |
Macrophage Colony-Stimulating Factor/pharmacology | 2 | 2.0 |
Prolactin/pharmacology | 2 | 5.0 |
Stimulation, Chemical | 2 | 0.0 |
Epidermal Growth Factor/*antagonists & inhibitors | 2 | 9.0 |
Membrane Proteins/*pharmacology | 2 | 4.0 |
Receptor, Epidermal Growth Factor/metabolism | 4 | 0.0 |
Growth Substances/*pharmacology | 3 | 0.0 |
Erythropoietin/*pharmacology | 3 | 2.0 |
Antibodies/immunology | 2 | 0.0 |
Trans-Activators/metabolism/physiology | 3 | 27.0 |
Transcription Factors/*genetics/*metabolism | 2 | 1.0 |
Endopeptidases/*genetics/metabolism | 2 | 18.0 |
Phosphoproteins/*physiology | 3 | 3.0 |
Interferon Type II/biosynthesis | 4 | 0.0 |
Receptors, Interferon/*genetics | 2 | 13.0 |
Bacterial Adhesion | 2 | 3.0 |
Cyclic AMP-Dependent Protein Kinases/*metabolism | 2 | 2.0 |
Inflammation | 7 | 1.0 |
Antiviral Agents/metabolism | 2 | 22.0 |
Ribosomal Protein S6 Kinases/metabolism | 2 | 2.0 |
Cell Division/drug effects/genetics | 3 | 3.0 |
Caspase 1 | 3 | 7.0 |
RNA, Double-Stranded/metabolism | 2 | 12.0 |
Prolactin/*pharmacology | 3 | 3.0 |
Cell Division/drug effects/immunology | 2 | 3.0 |
Lymphocyte Activation/*drug effects | 2 | 0.0 |
Transforming Growth Factor beta/*physiology | 2 | 1.0 |
Interleukin-10/pharmacology | 6 | 8.0 |
Gene Expression Regulation/drug effects/*immunology | 3 | 10.0 |
Immunosorbent Techniques | 3 | 1.0 |
Acute-Phase Proteins/*metabolism | 3 | 5.0 |
Transcription Factor, Sp1/*metabolism | 2 | 0.0 |
Lipopolysaccharides/antagonists & inhibitors/pharmacology | 2 | 9.0 |
Macrophage Activation/immunology | 2 | 5.0 |
Macrophages/immunology/metabolism | 3 | 6.0 |
Interferon Type II/*biosynthesis/genetics | 2 | 9.0 |
*Membrane Glycoproteins | 2 | 0.0 |
Tumor Necrosis Factor-alpha/antagonists & inhibitors/biosynthesis | 3 | 13.0 |
Protein-Tyrosine Kinase/*biosynthesis | 2 | 8.0 |
Prolactin/*physiology | 2 | 5.0 |
Neutrophils/*metabolism | 2 | 1.0 |
Membrane Glycoproteins/*metabolism | 5 | 1.0 |
Gene Silencing | 2 | 0.0 |
Serine/chemistry | 4 | 2.0 |
Terminology | 2 | 1.0 |
Genes, fos | 2 | 1.0 |
RANTES/metabolism | 2 | 3.0 |
Growth Hormone/*pharmacology | 6 | 8.0 |
Breast Neoplasms/pathology | 4 | 3.0 |
Cell Transformation, Neoplastic/genetics/*metabolism | 2 | 7.0 |
src-Family Kinases/*physiology | 2 | 5.0 |
Dactinomycin/pharmacology | 5 | 1.0 |
Epinephrine/pharmacology | 2 | 2.0 |
GTP-Binding Proteins/metabolism | 3 | 1.0 |
Receptors, Cell Surface/metabolism | 2 | 0.0 |
Receptors, Interleukin/*metabolism | 4 | 12.0 |
Intercellular Adhesion Molecule-1/*biosynthesis/genetics | 2 | 10.0 |
DNA-Binding Proteins/drug effects/genetics/*metabolism | 2 | 14.0 |
Signal Transduction/*drug effects/genetics | 2 | 20.0 |
Trans-Activators/drug effects/genetics/*metabolism | 2 | 16.0 |
Chemokines, CXC/metabolism | 2 | 2.0 |
Proto-Oncogene Proteins c-jun/metabolism | 2 | 1.0 |
Adenocarcinoma, Bronchiolo-Alveolar | 2 | 50.0 |
Culture Media, Conditioned/pharmacology | 3 | 1.0 |
Lung Neoplasms | 2 | 1.0 |
Promoter Regions (Genetics)/physiology | 3 | 1.0 |
Monocytes/*metabolism | 5 | 1.0 |
Oligopeptides/pharmacology | 2 | 1.0 |
Receptors, IgG/*biosynthesis/genetics | 2 | 50.0 |
Receptors, Interleukin-6 | 4 | 4.0 |
Protein-Tyrosine Kinase/genetics/physiology | 2 | 13.0 |
Carcinoma, Hepatocellular/pathology | 3 | 6.0 |
Liver Neoplasms/pathology | 3 | 6.0 |
Leukocytes, Mononuclear/*metabolism | 2 | 1.0 |
Receptors, Prolactin/genetics/metabolism | 2 | 40.0 |
*Chemokines, CXC | 2 | 3.0 |
Cytokines/*genetics/immunology | 2 | 22.0 |
DNA-Binding Proteins/genetics/immunology | 2 | 14.0 |
Interferon Type II/*immunology | 2 | 5.0 |
*Mitogen-Activated Protein Kinase Kinases | 2 | 2.0 |
Proto-Oncogene Proteins c-raf | 2 | 1.0 |
Receptors, Interleukin-2/*physiology | 2 | 9.0 |
Antigens, CD/*metabolism | 3 | 0.0 |
Dexamethasone/pharmacology | 3 | 0.0 |
Recombinant Fusion Proteins/biosynthesis/metabolism | 2 | 2.0 |
DNA-Binding Proteins/immunology/metabolism | 2 | 10.0 |
Trans-Activators/immunology/metabolism | 2 | 50.0 |
Molecular Structure | 2 | 0.0 |
Receptors, Interferon/chemistry/genetics/*metabolism | 2 | 25.0 |
Superoxides/metabolism | 2 | 0.0 |
Neoplasm Proteins/genetics/*metabolism | 2 | 1.0 |
Endothelium, Vascular/*cytology | 3 | 1.0 |
Interferon-alpha/*physiology | 3 | 23.0 |
RNA/chemistry | 2 | 2.0 |
Recombinant Proteins/chemistry | 2 | 0.0 |
Protein-Tyrosine Kinase/genetics/metabolism | 2 | 2.0 |
Liver/cytology/drug effects/*metabolism | 2 | 10.0 |
Receptors, Cytokine/physiology | 2 | 7.0 |
Vanadates/*pharmacology | 2 | 8.0 |
Macrophage Colony-Stimulating Factor/*pharmacology | 2 | 5.0 |
Biopolymers | 2 | 1.0 |
Promoter Regions (Genetics)/drug effects | 4 | 3.0 |
Antigens, CD/genetics/metabolism | 2 | 3.0 |
Receptors, Interferon/genetics/metabolism | 2 | 33.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/metabolism | 2 | 3.0 |
Adenovirus E1A Proteins/metabolism | 2 | 6.0 |
Glutathione Transferase/biosynthesis | 2 | 6.0 |
DNA-Binding Proteins/*genetics/physiology | 2 | 2.0 |
Phosphoproteins/genetics/physiology | 2 | 14.0 |
Transcription Factors/*genetics/physiology | 2 | 2.0 |
Cell Nucleus/chemistry/*metabolism | 2 | 13.0 |
DNA Fragmentation | 2 | 0.0 |
DNA-Binding Proteins/antagonists & inhibitors/genetics/*metabolism | 2 | 9.0 |
DNA-Binding Proteins/*genetics/metabolism/*physiology | 2 | 20.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology | 3 | 0.0 |
Burkitt Lymphoma/*genetics/pathology/virology | 2 | 100.0 |
Cyclin-Dependent Kinases/metabolism | 2 | 0.0 |
Recombinant Proteins/biosynthesis/metabolism | 4 | 2.0 |
Restriction Mapping | 3 | 0.0 |
Membrane Glycoproteins/*genetics | 2 | 0.0 |
Protein-Tyrosine Kinase/immunology/*metabolism | 2 | 10.0 |
Trans-Activators/drug effects/metabolism | 3 | 14.0 |
Reticulocytes/metabolism | 3 | 4.0 |
Ubiquitin/metabolism | 2 | 0.0 |
DNA | 5 | 0.0 |
Phosphotyrosine/*metabolism | 2 | 3.0 |
Receptors, IgG/*genetics | 2 | 9.0 |
Cell Death | 2 | 0.0 |
Lymphocytes/*metabolism | 3 | 1.0 |
Antibodies | 3 | 0.0 |
DNA-Binding Proteins/isolation & purification/*metabolism | 4 | 5.0 |
Phosphotyrosine | 9 | 3.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Receptors, Interleukin-4 | 2 | 2.0 |
Sheep | 4 | 0.0 |
Phosphoproteins/isolation & purification/metabolism | 2 | 5.0 |
DNA Probes/genetics | 2 | 1.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 3 | 0.0 |
DNA-Binding Proteins/biosynthesis/isolation & purification/*metabolism | 3 | 20.0 |
Trans-Activators/biosynthesis/isolation & purification/*metabolism | 2 | 66.0 |
Oligodeoxyribonucleotides/chemistry | 3 | 1.0 |
Cytoplasm | 2 | 3.0 |
Gene Targeting | 2 | 0.0 |
*Genes, jun | 2 | 4.0 |
Trans-Activators/isolation & purification/*metabolism | 4 | 30.0 |
*Protein Processing, Post-Translational | 2 | 0.0 |
Interleukin-12/*immunology | 2 | 13.0 |
Cytokines/genetics/*metabolism | 2 | 5.0 |
Interferon Type II/genetics/*metabolism | 2 | 40.0 |
Acute-Phase Proteins | 2 | 11.0 |
Epidermal Growth Factor/metabolism | 2 | 0.0 |
*Regulatory Sequences, Nucleic Acid | 3 | 0.0 |
Tyrosine/analogs & derivatives/analysis | 2 | 5.0 |
1-(5-Isoquinolinesulfonyl)-2-methylpiperazine | 2 | 3.0 |
Piperazines/*pharmacology | 2 | 3.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Receptors, Cytokine/metabolism | 3 | 3.0 |
Phosphopeptides/*metabolism | 2 | 20.0 |
Protein Binding/physiology | 4 | 1.0 |
DNA Mutational Analysis | 4 | 0.0 |
Piperazines/pharmacology | 2 | 1.0 |
Protein-Tyrosine Kinase/genetics/*metabolism | 4 | 2.0 |
Tyrosine/analogs & derivatives/metabolism | 3 | 2.0 |
Protein Structure, Tertiary/genetics/physiology | 2 | 6.0 |
Cytokines/biosynthesis | 2 | 0.0 |
Carrier Proteins/biosynthesis | 3 | 5.0 |
Temperature | 2 | 0.0 |
CD4-Positive T-Lymphocytes/immunology | 2 | 0.0 |
Interferon Type II/immunology/metabolism | 2 | 14.0 |
Macrophages/drug effects/metabolism | 2 | 4.0 |
Tyrosine/*chemistry/metabolism | 2 | 40.0 |
Oligonucleotide Array Sequence Analysis/methods | 2 | 2.0 |
Viral Load/methods | 2 | 18.0 |
*Amino Acid Sequence | 2 | 12.0 |
Carrier Proteins/biosynthesis/genetics | 2 | 5.0 |
Interleukin-6/metabolism | 4 | 1.0 |
Killer Cells, Natural/*immunology | 2 | 0.0 |
Survival Analysis | 3 | 0.0 |
Membrane Glycoproteins/*biosynthesis/genetics | 2 | 3.0 |
Tumor Necrosis Factor-alpha/*biosynthesis/genetics | 2 | 2.0 |
SUMO-1 Protein/*metabolism | 3 | 10.0 |
Interferon Type I/pharmacology/*physiology | 2 | 100.0 |
Poly I-C/pharmacology | 2 | 8.0 |
Caspases/*metabolism | 3 | 1.0 |
Immunoglobulins/metabolism | 2 | 1.0 |
Viral Proteins/*chemistry/genetics/*metabolism | 2 | 40.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism/*physiology | 2 | 10.0 |
Interferon-alpha/immunology/*metabolism | 2 | 100.0 |
Models, Immunological | 2 | 0.0 |
Protein Subunits/metabolism | 2 | 4.0 |
Oxidation-Reduction | 2 | 0.0 |
Apoptosis/drug effects/physiology | 2 | 2.0 |
Trans-Activators/*antagonists & inhibitors | 2 | 15.0 |
DNA-Binding Proteins/analysis/*genetics | 2 | 6.0 |
Trans-Activators/analysis/*genetics | 2 | 28.0 |
Drug Interactions | 3 | 0.0 |
Chickens | 2 | 0.0 |
Reproducibility of Results | 2 | 0.0 |
Antibodies, Monoclonal/metabolism | 2 | 0.0 |
Th2 Cells/*immunology | 2 | 1.0 |
Trans-Activators/*antagonists & inhibitors/metabolism/physiology | 2 | 50.0 |
Tumor Markers, Biological/analysis | 2 | 0.0 |
RNA, Messenger/antagonists & inhibitors/biosynthesis | 2 | 8.0 |
Chromatography | 2 | 1.0 |
RNA/*metabolism | 2 | 3.0 |
1-Phosphatidylinositol 3-Kinase/metabolism/physiology | 2 | 20.0 |
Antigens, CD40/metabolism | 2 | 3.0 |
Gene Expression Regulation, Viral | 2 | 0.0 |
Antigens, CD2/*physiology | 2 | 8.0 |
Trans-Activation (Genetics)/*immunology | 2 | 10.0 |
Ubiquitin-Protein Ligases | 2 | 0.0 |
Spleen/cytology | 2 | 1.0 |
Leukocytes, Mononuclear/drug effects/immunology/metabolism | 2 | 14.0 |
Leukocytes/*cytology | 2 | 10.0 |
ras Proteins/metabolism | 2 | 1.0 |
Oligonucleotides/metabolism | 2 | 2.0 |
Nitric Oxide/metabolism | 2 | 1.0 |
*Carcinoma, Hepatocellular | 2 | 12.0 |
*Liver Neoplasms | 2 | 10.0 |
*Antigens, CD3 | 2 | 10.0 |
Receptors, Antigen, T-Cell/genetics | 2 | 2.0 |
T-Lymphocytes/*enzymology | 2 | 3.0 |